Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Definition and epidemiology of treatment-resistant depression.

Fava M, Davidson KG.

Psychiatr Clin North Am. 1996 Jun;19(2):179-200. Review.

PMID:
8827185
2.

[Antidepressants consumption in the global population in France].

Olié JP, Elomari F, Spadone C, Lépine JP.

Encephale. 2002 Sep-Oct;28(5 Pt 1):411-7. French.

PMID:
12386542
3.
4.

Nonsomatic treatment of depression.

Sherrill JT, Kovacs M.

Child Adolesc Psychiatr Clin N Am. 2002 Jul;11(3):579-93. Review.

PMID:
12222084
5.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628
6.

[Tricyclic antidepressants dosage and depressed elderly inpatients: a retrospective pharmaco-epidemiologic study].

Ballon N, Siobud-Dorocant E, Even C, Slama F, Dardennes R.

Encephale. 2001 Jul-Aug;27(4):373-6. French.

PMID:
11686060
8.

Nortriptyline for treatment-resistant depression.

Nierenberg AA, Papakostas GI, Petersen T, Kelly KE, Iacoviello BM, Worthington JJ, Tedlow J, Alpert JE, Fava M.

J Clin Psychiatry. 2003 Jan;64(1):35-9.

PMID:
12590621
9.

[Antidepressants and their onset of action: a major clinical, methodological and pronostical issue].

Gourion D.

Encephale. 2008 Jan;34(1):73-81. doi: 10.1016/j.encep.2007.12.001. Epub 2008 Feb 5. Review. French.

PMID:
18514154
10.

A closer look at treatment resistant depression: is it due to a bipolar diathesis?

Sharma V, Khan M, Smith A.

J Affect Disord. 2005 Feb;84(2-3):251-7.

PMID:
15708423
12.

Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.

Brady KT, Clary CM.

Compr Psychiatry. 2003 Sep-Oct;44(5):360-9.

PMID:
14505296
13.

Efficacy of bupropion in tricyclic-resistant or intolerant patients.

Stern WC, Harto-Truax N, Bauer N.

J Clin Psychiatry. 1983 May;44(5 Pt 2):148-52.

PMID:
6406447
14.

Treatment-resistant depression.

Little A.

Am Fam Physician. 2009 Jul 15;80(2):167-72. Review.

15.

Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.

Henkel V, Seemüller F, Obermeier M, Adli M, Bauer M, Mundt C, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Mayr A, Möller HJ, Riedel M.

J Affect Disord. 2009 Jun;115(3):439-49. doi: 10.1016/j.jad.2008.10.011. Epub 2008 Nov 22.

PMID:
19027961
16.

The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?

Fava M, Mallinckrodt CH, Detke MJ, Watkin JG, Wohlreich MM.

J Clin Psychiatry. 2004 Apr;65(4):521-30.

PMID:
15119915
17.

Venlafaxine and paroxetine in treatment-resistant depression. Double-blind, randomised comparison.

Poirier MF, Boyer P.

Br J Psychiatry. 1999 Jul;175:12-6. Erratum in: Br J Psychiatry 1999 Oct;175:394.

PMID:
10621762
18.

Treating each and every depressed patient.

Kennedy SH.

J Psychopharmacol. 2008 Sep;22(7 Suppl):19-23. doi: 10.1177/0269881108093270. Review.

PMID:
18753279
19.

Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.

Nierenberg AA, Greist JH, Mallinckrodt CH, Prakash A, Sambunaris A, Tollefson GD, Wohlreich MM.

Curr Med Res Opin. 2007 Feb;23(2):401-16.

PMID:
17288694
20.

Therapeutic considerations in treating depression in the elderly.

Dunner DL.

J Clin Psychiatry. 1994 Dec;55 Suppl:48-58; discussion 59-60. Review.

PMID:
7814358

Supplemental Content

Support Center